13 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
New Strong Sell Stocks for March 18th https://www.zacks.com/stock/news/2242230/new-strong-sell-stocks-for-march-18th?cid=CS-ZC-FT-tale_of_the_tape|new_zacks_5_rank_stocks-2242230 Mar 18, 2024 - ACNB, AMPH and TRDA have been added to the Zacks Rank #5 (Strong Sell) List on March 18, 2024.
3 Generic Drug Stocks to Watch Amid Improving Market Prospects https://www.zacks.com/commentary/2215536/3-generic-drug-stocks-to-watch-amid-improving-market-prospects?cid=CS-ZC-FT-industry_outlook-2215536 Jan 25, 2024 - With the ease in inflationary pressure, the Zacks Medical - Generic Drugs industry is expected to benefit from declining costs. New product launches provide some respite to AMPH, RDY and TEVA.
Centene (CNC) Chosen to Serve New Hampshire's Medicaid Members https://www.zacks.com/stock/news/2212996/centene-cnc-chosen-to-serve-new-hampshire-s-medicaid-members?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2212996 Jan 19, 2024 - Centene's (CNC) subsidiary has been selected by the DHHS to serve the diversified health needs of members of New Hampshire's Medicaid program and thereby, earn more members.
Snap these 4 Top-Ranked Liquid Stocks to Drive Solid Returns https://www.zacks.com/stock/news/2209962/snap-these-4-top-ranked-liquid-stocks-to-drive-solid-returns?cid=CS-ZC-FT-analyst_blog|rw-2209962 Jan 15, 2024 - Here are four top-performing liquid stocks, American Public Education (APEI), Amphastar Pharmaceuticals (AMPH), GigaCloud (GCT) and Oceaneering International (OII), which investors can add to their portfolio to boost returns.
Amphastar Pharmaceuticals (AMPH) Is Up 1.53% in One Week: What You Should Know https://www.zacks.com/stock/news/2204183/amphastar-pharmaceuticals-amph-is-up-1-53-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2204183 Jan 01, 2024 - Does Amphastar Pharmaceuticals (AMPH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here's Why You Should Retain Centene (CNC) Stock For Now https://www.zacks.com/stock/news/2203857/here-s-why-you-should-retain-centene-cnc-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2203857 Dec 29, 2023 - Centene (CNC) remains well-poised for growth on the back of overall membership growth, acquisitions, business streamlining efforts and a growing cash balance.
Are Medical Stocks Lagging Arch Therapeutics (ARTH) This Year? https://www.zacks.com/stock/news/2202634/are-medical-stocks-lagging-arch-therapeutics-arth-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2202634 Dec 27, 2023 - Here is how Arch Therapeutics, Inc. (ARTH) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.
Wall Street Analysts Think Amphastar (AMPH) Is a Good Investment: Is It? https://www.zacks.com/stock/news/2202621/wall-street-analysts-think-amphastar-amph-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2202621 Dec 27, 2023 - According to the average brokerage recommendation (ABR), one should invest in Amphastar (AMPH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
5 Good Opportunities on Relative Price Strength Strategy https://www.zacks.com/stock/news/2202102/5-good-opportunities-on-relative-price-strength-strategy?cid=CS-ZC-FT-analyst_blog|rw-2202102 Dec 26, 2023 - AMPH, FOUR, BECN, HOFT and HTH are five stocks with explosive relative price strength.
What's in Store for Nasdaq in 2024? 5 Top Picks https://www.zacks.com/stock/news/2196609/what-s-in-store-for-nasdaq-in-2024-5-top-picks?cid=CS-ZC-FT-analyst_blog|investment_ideas-2196609 Dec 12, 2023 - After a strong 2023, we expect the Nasdaq to log gains in 2024. Top-ranked Nasdaq stocks GigaCloud Technology Inc (GCT), Carrols Restaurant Group (TAST), Limbach (LMB), Amphastar Pharmaceuticals (AMPH) and Insight Enterprises Inc (NSIT) could emerge as winning picks.

Pages: 12

Page 1